IQ4I Research & Consultancy Published a New Report on “Cell Analysis Global Market”: Estimated to be Worth $35.4 Billion by 2020

Vancouver, WA, April 03, 2015 --(PR.com)-- IQ4I Research & Consultancy published a new report on “Cell Analysis Global Market – Forecast To 2020” analyzes and studies the major market drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World.

IQ4I’s Report Contains 158 market data tables and 35 figures spread through 423 pages and an exhaustive TOC on “Cell Analysis Global Market – Forecast To 2020.”

The global Cell Analysis market is expected to reach $35.4 billion by 2020. This report analyzes the cell analysis market in terms of market revenue for all segments. The market analysis is performed by Technique (Molecular-based approaches, Image-based approaches), Products (Consumables, Instruments & Others), Applications (By process, By-Field & By-Therapeutic areas), end-user (Hospitals, Academic & Research Institutes, CROs, Pharma & Biotech Companies, Cell Banks, Diagnostic Labs & Others) and Regional markets (North America, Europe, Asia-Pacific and Rest of the World).

The booming healthcare technology market with demand for innovative technology for early and accurate diagnosis of life threatening diseases, increasing government and corporate funding and investment in cell based research, higher demand from end users such as diagnostic laboratories for cell analysis products are some of the factors driving the cell analysis market growth. However as usually, stringent government regulations, lack of skilled personnel to perform some of cell analysis techniques like High Content Screening, NGS etc., and high cost of some of the commercial instruments are expected to hamper the market growth.

In 2013, the North America accounted for the largest share in 2013. High investments in healthcare infrastructures, availability of government funds improved market growth in this region. Asia-Pacific (APAC) region is expected to grow at the highest CAGR during the forecast period due to increased healthcare awareness, improved economic growth and increasing disposable incomes. Significant mergers and acquisitions, collaborations, joint ventures are the industry trends that are playing a major role for the market growth.

Danaher Corporation is the largest player in the Cell analysis market with a shares, followed by Thermo Fisher Scientific and Becton Dickinson accounting, and shares respectively in 2013. The Cell analysis market is consolidated, with major players accounting for more than 80% market share in 2013. Top ten major players in the global cell analysis market include Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck KGaA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands), Sigma Aldrich (U.S.) and Thermo Fisher Scientific, Inc. (U.S.).

Reasons for buying this report:
· Market assessment of all segments and sub segments of Cell analysis market
· In-depth market sizing analysis of various segments and sub segments of Techniques, Products, Applications, End-Users and Regional markets
· Regulatory scenario across the globe
· Latest and Upcoming Products
· On-going Researches and funding agencies
· Market share analysis of key players
· Major player profiles and their competitive landscaping